This chapter focuses on the importance of shared decision-making and regular, long-term monitoring of histology and endoscopy, not just symptoms.
The digital EoE Pocket Guide is an at-your-fingertips resource on symptoms and adaptive behaviors, EREFS scoring, and histologic features in EoE.
Professor Dédée Murrell explains the challenges in managing patients with bullous pemphigoid at EADV 2025.
Professor Dédée Murrell highlights the importance of early diagnosis in bullous pemphigoid at EADV 2025
Expert gastroenterologist Dr. Ikuo Hirano highlights the endoscopic features in EoE and reviews the EREFS scoring system to assess disease activity.
Expert gastroenterologist Dr. Ikuo Hirano reviews the histologic features of EoE and provides insights on their assessment.

Learn about patient concerns in EoE and the benefits of adequate monitoring and effective maintenance therapy on disease control and QoL

In this clip from the April WCPD 2025 symposium, Dr Paula Luna discusses how moderate-to-severe AD may hinder growth in pediatric patients.

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller discusses how moderate-to-severe AD may hinder growth in pediatric patients and highlights data showing treatment with dupilumab may increase vertical growth in children of lower stature.

Drs Donna Culton and Russell Hall explore the Burden of Disease and Diagnosis of BP.
This infographic examines the increased risk of low bone mineral density and impaired vertical growth observed in pediatric atopic dermatitis (AD). It also presents data demonstrating that dupilumab treatment is associated with improvements in growth compared to placebo and conventional systemic therapies in pediatric AD.

This infographic explores distensibility in EoE, including assessment with EndoFLIP.